相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B
Josiane F. John et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency
Visanu Thamlikitkul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Critical Need for Clarity in Polymyxin B Dosing
Nikolas J. Onufrak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing
J. M. Pogue et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B
Maria Helena Rigatto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins?
Jason M. Pogue et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Major Pathways of Polymyxin-Induced Apoptosis in Rat Kidney Proximal Tubular Cells
Mohammad A. K. Azad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods
Brian C. Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Polymyxin B versus colistin: an update
Yiying Cai et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Risk factors for nephrotoxicity onset associated with polymyxin B therapy
Yanina Dubrovskaya et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
To B or Not to B, That Is the Question: Is It Time to Replace Colistin With Polymyxin B?
Zahra Kassamali et al.
PHARMACOTHERAPY (2015)
In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
Kady Phe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
Roger L. Nation et al.
CLINICAL INFECTIOUS DISEASES (2014)
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium
Felipe F. Tuon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy
Robbert Crusio et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
Erik von Elm et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
Polymyxins: Wisdom Does Not Always Come With Age
Zahra Kassamali et al.
CLINICAL INFECTIOUS DISEASES (2013)
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
Ana M. Sandri et al.
CLINICAL INFECTIOUS DISEASES (2013)
Model Selection and Psychological Theory: A Discussion of the Differences Between the Akaike Information Criterion (AIC) and the Bayesian Information Criterion (BIC)
Scott I. Vrieze
PSYCHOLOGICAL METHODS (2012)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
R Bellomo et al.
CRITICAL CARE (2004)
分享论文
